4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-031265
Chief Operating Officer gave up 239 shares (to pay taxes)
- Chief Operating Officer acquired 613 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Williams Paul Christopher Chief Operating Officer | 2023-05-18 | Option exercise | +613 | 613 | D | ||
| Williams Paul Christopher Chief Operating Officer | 2023-05-18 | Shares withheld for taxes | −239 | $6.69 | $1,599 | 374 | D |
| Derivatives | |||||||
| Williams Paul Christopher Chief Operating Officer | 2023-05-18 | Option exercise · Restricted Stock Units | −613 | 14,113 | D | ||
Loading xslF345X04/doc4.xml…